Emerging nonspecific migraine therapies: Targets and unmet needs

Headache

Volumn 39, Issue SUPPL. 2, 1999, Pages

  Rapoport, Alan M ^a,b  

^a NEW ENGLAND CENTER FOR HEADACHE   (United States)

^b NONE   (United States)

Author keywords

Nonpharmacologic therapies; Nonprescription medications; Nonspecific migraine therapies; Prescription medications

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BUTALBITAL; CAFFEINE; CAFFEINE DERIVATIVE; CHAMOMILE; CORTICOSTEROID; DIHYDROERGOTAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; ERGOT DERIVATIVE; GINKGO BILOBA EXTRACT; GUAR GUM; ICOSAPENTAENOIC ACID; ISOMETHEPTENE MUCATE; MAGNESIUM; MUSCLE RELAXANT AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; RIBOFLAVIN;

BEHAVIOR THERAPY; BODY POSTURE; CONFERENCE PAPER; DISEASE SEVERITY; EXERCISE; GINGER; MENTAL STRESS; MIGRAINE; NAUSEA; PATIENT EDUCATION; PRIORITY JOURNAL; SLEEP PATTERN; TANACETUM PARTHENIUM;

EID: 0033428967     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.1999.00007.x     Document Type: Conference Paper

References (31)

1. Rapoport AM, Sheftell FD, Headache Disorders: A Management Guide for Practitioners. Philadelphia: WB Saunders Company; 1996.
2. Rapoport A, Sheftell F. Conquering Headache. Hamilton, ON: Empowering Press; 1995.
3. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache. 1996;36:14-19.
4. Saper JR, Silberstein S, Gordon CD, Hamel RL. Handbook of Headache Management: A Practical Guide to Diagnosis and Treatment of Head, Neck, and Facial Pain. Baltimore: Williams & Wilkins; 1993.
5. Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia. 1985;5:5-10.
6. Pradalier A, Rancurel G, Dordain G, Verdure L, Rascol A, Dry J. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia. 1985;5:107-113.
7. Nestvold K, Kloster R, Partinen M, Sulkava R. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia. 1985;5:115-119.
8. Karachalios GN, Fotiadou A, Chrisikos N, Karabetsos A, Kehagioglou K. Treatment of acute migraine attack with diclofenac sodium: a double-blind study. Headache. 1992;32:98-100.
9. Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia. 1992;12:169-171.
10. Klapper JA, Stanton JS. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache. 1991;31:523-524.
11. Welch KM. Drug therapy of migraine. N Engl J Med. 1993;329:1476-1483.
12. Bowdle TA, Galer BS. Agonist-antagonist and partial agonist opioids: pharmacologic mechanisms and clinical application in the treatment of headache. Headache Q. 1993;4:322-336.
13. Wang SJ, Silberstein SD, Young WB. Droperidol treatment of status migrainosus and refractory migraine. Headache. 1997;37:377-382.
14. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology. 1994;44(suppl 7): S6-S16.
15. Winner P, Ricalde O, Le Force B, Saper J, Margul B. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996;53:180-184.
16. Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bès A. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology. 1996;47:361-365.
17. Gallagher RM. Acute treatment of migraine with dihydroergotamine nasal spray. Arch Neurol. 1996; 53:1285-1291.
18. Henryk-Gutt R, Rees WL. Psychological aspects of migraine. J Psychosom Res. 1973;17:141-153.
19. Barnat MR, Lake AE, III. Patient attitudes about headache. Headache. 1983;23:229-237.
20. Wauquier A, McGrady A, Aloe L, Klausner T, Collins B. Changes in cerebral blood flow velocity associated with biofeedback-assisted relaxation treatment of migraine headaches are specific for the middle cerebral artery. Headache. 1995;35:358-362.
21. Larsson B, Melin L. Chronic headaches in adolescents: treatment in a school setting with relaxation training as compared with information-contact and self-registration. Pain. 1986;25:325-336.
22. Lake A, Rainey J, Papsdorf JD. Biofeedback and rational-emotive therapy in the management of migraine headache. J Appl Behav Anal. 1979;12:127-140.
23. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50:466-470.
24. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16:257-263.
25. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine - a double-blind placebo-controlled study. Cephalalgia. 1996;16: 436-440.
26. Facchinetti F, Sances G, Bonella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effect on intracellular magnesium. Headache. 1991;31:298-301.
27. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache. 1996;36:154-160.
28. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. BMJ. 1985;291:569-573.
29. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. 1988;2:189-192.
30. Wagner W, Nootbaar-Wagner U. Prophylactic treatment of migraine with gamma-linolenic and alpha-linolenic acids. Cephalalgia. 1997;17:127-130.
31. Lipton RB, Stewart WF, Ryan RE Jr, Saper J, Silberstein S, Sheftell F. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Arch Neurol. 1998;55:210-217.